Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 2Solid Tumor, Adult 2Advanced Solid Tumors 2Advanced Solid Tumor 2Advanced Refractory Solid Tumors 2Urinary Bladder Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1Melanoma 1MSI-H Advanced Colorectal Cancer 1Immune-related Adverse Event 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Malignant Solid Tumors 1Advanced Malignant Solid Tumor 1

Interventions

vorolanib 3neratinib 3toripalimab 1dacomitinib 1Vinorelbine 1TAK-243 1Premedication 1Paclitaxel 1Injections 1Immune Checkpoint Inhibitors 1Clinical Trials, Phase II as Topic 1Capecitabine 11-(4-(4-(3-oxa-8-azabicyclo(3.2.1)octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumors × Immune Checkpoint Inhibitors × Other solid neoplasm × Clear all
NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

West China Hospital

Phase 1 Not yet recruiting
10 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡